← Evidence map

ArticleAnticancer research2016

Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell Lines.

Dong-Joon Min et al.PubMed ↗Full text ↗

No numbers read from the abstract.

4 papers cite it

2016

2017

2018

2019

2020

2021

2022

2023

2024

this paperpooled itcites it

Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell Lines. | OpenQuestion